Clinical Trial Update: Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing symptom outcomes in adults with erosive GERD or endoscopic-negative GERD after pantoprazole treatment; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: Takeda | Conditions: GERD | Phase 3 | Status: COMPLETED